Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	27.62B
Revenue (ttm)	1.82B
Net Income (ttm)	246.00M
Shares Out	n/a
EPS (ttm)	0.57
PE Ratio	112.26
Forward PE	n/a
Dividend	0.00 (0.02%)
Ex-Dividend Date	Jun 26, 2025

Volume	10,816,642
Average Volume	3,443,315
Open	20.60
Previous Close	20.76
Day's Range	19.56 - 22.30
52-Week Range	7.88 - 28.70
Beta	n/a
RSI	54.22
Earnings Date	Oct 30, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY